The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes

OBJECTIVE: Basal insulin glargine has a neutral effect on cardiovascular risk in type 2 diabetes (T2DM). In practice, basal insulin is often paired with a glucagon-like peptide-1 receptor agonist (GLP1-RA) or meal insulin; however, the cardiovascular implications of these combinations have not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Retnakaran, Ravi, Pu, Jiajie, Ye, Chang, Emery, Alexandra, Kramer, Caroline K., Zinman, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998007/
https://www.ncbi.nlm.nih.gov/pubmed/36894921
http://dx.doi.org/10.1186/s12933-023-01781-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998007/
https://www.ncbi.nlm.nih.gov/pubmed/36894921
http://dx.doi.org/10.1186/s12933-023-01781-z

Ejemplares similares